,trastuzumab deruxtecan
Daiichi Sankyo,AstraZeneca
['enhertu', 'pivotal']
db-04 reviewer p lorusso discusses potential resistance mechanisms to enhertu, says pivotal to figure this out so best combinations can be tested #asco22 
Pharma and biotech reporter, found a home at Evaluate Vantage.